The Department of Cognitive Disorders at the Mount Sinai Health System, housed at the Barbara and Maurice Deane Center for Wellness and Cognitive Health, consists of a multi-disciplinary team of neurologists, psychiatrists, neurohospitalists, neuropsychologists, neuroscientists, and patient care managers. Our mission is to provide a global interdisciplinary approach to care for persons living with dementia and a wide range of other cognitive disorders, including:
- Alzheimer’s disease
- Attention deficit disorder
- Dementia with Lewy bodies disease
- Early onset dementia
- Epilepsy-related cognitive dysfunction
- Fronto-temporal dementia
- Mild cognitive impairment
- Normal pressure hydrocephalus
- Parkinson’s disease-related cognitive dysfunction
- Posterior cortical atrophy
- Primary progressive aphasia
- Stroke-related cognitive dysfunction
- Traumatic brain injury
- Other neurologic disorder-related cognitive impairments (e.g., multiple sclerosis)
- Chemotherapy-related cognitive impairment (chemo-brain)
We also support those in the growing population of older adults who have healthy brains and bodies.
Please visit The Barbara and Maurice Deane Healthy Brain Initiative webpage for information on conditions we treat, neurological examinations, preparing for your first visit, and more information on the Healthy Brain Initiative.
Our clinical trials program offers rapid access to emerging therapies for patients and their families who have already seen a doctor and are frustrated with the progression of their illness.
As a unit of the Friedman Brain Institute, we run a wide range of research programs to help us understand the underlying causes of cognitive and related neuropsychiatric disorders.
Our goal is to translate these insights into effective treatments to improve the lives of people suffering from cognitive disorders.